BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22200537)

  • 1. Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines.
    Jinturkar KA; Anish C; Kumar MK; Bagchi T; Panda AK; Misra AR
    Biomaterials; 2012 Mar; 33(8):2492-507. PubMed ID: 22200537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
    Yoo J; Park SS; Lee YJ
    J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
    Chiu CC; Lin CH; Fang K
    Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
    Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
    Zou Y; Zong G; Ling YH; Perez-Soler R
    Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM
    Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and
    Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.
    Horio Y; Hasegawa Y; Sekido Y; Takahashi M; Roth JA; Shimokata K
    Cancer Gene Ther; 2000 Apr; 7(4):537-44. PubMed ID: 10811471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
    Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
    Amiri F; Zarnani AH; Zand H; Koohdani F; Jeddi-Tehrani M; Vafa M
    Eur J Pharmacol; 2013 Oct; 718(1-3):34-40. PubMed ID: 24055188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
    Jain S; Kumar D; Swarnakar NK; Thanki K
    Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine.
    McNeill-Blue C; Wetmore BA; Sanchez JF; Freed WJ; Merrick BA
    Brain Res; 2006 Sep; 1112(1):1-15. PubMed ID: 16901471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
    Serafin AM; Akudugu JM; Bohm L
    Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
    Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.